We are live on
!
Find out more
RA
Ruggaard & Associates Portfolio holdings
AUM
$252M
1-Year Est. Return
14.53%
This Fund
S&P 500
This Quarter
Est. Return
-0.18%
1 Year Est. Return
+14.53%
3 Year Est. Return
+39.1%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$228M
AUM Growth
-$1.71M
(-0.74%)
Cap. Flow
-$565K
Cap. Flow
% of AUM
-0.25%
Top 10 Holdings %
Top 10 Hldgs %
57.25%
Holding
118
New
2
Increased
40
Reduced
46
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$474K |
| 2 |
Capital Group Core Plus Income ETF
CGCP
|
+$428K |
| 3 |
Dimensional US Small Cap ETF
DFAS
|
+$355K |
| 4 |
American Century US Quality Growth ETF
QGRO
|
+$333K |
| 5 |
PIMCO Multi Sector Bond Active ETF
PYLD
|
+$280K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$462K |
| 2 |
Regeneron Pharmaceuticals
REGN
|
+$372K |
| 3 |
Mercado Libre
MELI
|
+$314K |
| 4 |
Tractor Supply
TSCO
|
+$291K |
| 5 |
Dollar General
DG
|
+$246K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.92% |
| 2 | Financials | 2.65% |
| 3 | Energy | 2.12% |
| 4 | Consumer Staples | 1.51% |
| 5 | Healthcare | 1.51% |
Similar funds
PI
MFP
ORC
IWP
N
JWM
ACM
SHA
Ruggaard & Associates's Q4 2024 Portfolio in Review
As of Q4 2024, Ruggaard & Associates held 118 positions worth $228M, down 0.74% from $230M the previous quarter. Its ten largest holdings account for 57% of the portfolio.
Ruggaard & Associates's Q4 2024 filing shows 2 new, 40 increased, 46 reduced and 8 closed positions. Its largest new stake was Broadcom: 1,050 shares worth $243K. The largest sale was Apple, an estimated $462K.
By sector, the portfolio is most concentrated in Technology at 5.9% of assets, down from 5.9% a quarter earlier, followed by Financials and Energy.
- Ruggaard & Associates's largest Q4 2024 buy was Broadcom: 1,050 shares worth $243K.
- Ruggaard & Associates added most to JPMorgan Ultra-Short Income ETF in Q4 2024, an estimated $474K increase.
- Ruggaard & Associates's biggest Q4 2024 reduction was Apple, cutting an estimated $462K.
- Ruggaard & Associates fully exited Regeneron Pharmaceuticals in Q4 2024, selling an estimated $372K.
- Ruggaard & Associates's ten largest holdings make up 57% of its $228M portfolio in Q4 2024.
- Ruggaard & Associates opened 2 new positions and closed 8 in Q4 2024.
- Ruggaard & Associates's portfolio value fell 0.74% quarter-over-quarter to $228M.
Based on Ruggaard & Associates's 13F filing for Q4 2024, filed 13 Feb 2025.